Friday April 26, 2019 23:16

Heathcare Press Release : 25 Mar 2019

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared Heathcare—25 Mar 19

Oral semaglutide 7 mg and 14 mg demonstrated superior HbA1c and body weight reductions compared to Januvia(R) (sitagliptin 100 mg). Non-inferiority for oral semaglutide 3 mg for HbA1c reductions at 26 weeks was not confirmed. Presented today at the